Biotech News

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Rapid Micro Biosystems (RPID)Rapid Micro Biosystems2026-03-12 11:00 ESTEarnings

Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024 Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024 Amgen expands global Growth Direct system rollout with significant multi-system

Rapid Micro Biosystems

Automated Microbial Quality Control Rapid Micro Biosystems provides automation systems used to test biologics, vaccines, cell and gene therapies, sterile injectables, and other healthcare products for microbial contamination. Growth Direct Platform The Growth Direct system replaces manual microbial quality-control workflows with...

Recent company news

RPIDRapid Micro Biosystems2026-08-07 11:00 EST

Stock data

Close: 1.68 USD
Market cap: 97.65M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Related news

Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Rapid Micro Biosystems

Recent company news

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

Stock data